Quantum-Si demonstrates detection of 19 amino acids in Proteus development program
Quantum-Si said it has demonstrated detection of 19 amino acids in its Proteus development program and is now working to deploy that capability into a developmental sequencing kit for R&D use. The company reaffirmed its target of demonstrating detection of all 20 amino acids by year-end 2026 and its planned commercial launch of Proteus in the second quarter of 2027, but the filing contains no financial results.
Key points
- Detection of 19 amino acids demonstrated in the Proteus development program, announced October 8, 2026
- Previously, a developmental kit detecting 18 amino acids was presented at the 2026 World HUPO Congress
- Company target is detection of all 20 amino acids by year-end 2026
- Proteus commercial launch is planned for the second quarter of 2027
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 08, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.